Chemoinformaics analysis of N-(2-Hydroxyethyl)dodecanamide
Molecular Weight | 243.391 | nRot | 12 |
Heavy Atom Molecular Weight | 214.159 | nRig | 1 |
Exact Molecular Weight | 243.22 | nRing | 0 |
Solubility: LogS | -1.62 | nHRing | 0 |
Solubility: LogP | 2.19 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 29 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 45.421 |
nHD | 2 | BPOL | 30.531 |
QED | 0.542 |
Synth | 2.488 |
Natural Product Likeliness | 1.045 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.002 |
HIA | 0.004 |
CACO-2 | -4.277 |
MDCK | 0.0000294 |
BBB | 0.997 |
PPB | 0.380361 |
VDSS | 1.021 |
FU | 0.71477 |
CYP1A2-inh | 0.624 |
CYP1A2-sub | 0.12 |
CYP2c19-inh | 0.08 |
CYP2c19-sub | 0.783 |
CYP2c9-inh | 0.036 |
CYP2c9-sub | 0.147 |
CYP2d6-inh | 0.044 |
CYP2d6-sub | 0.219 |
CYP3a4-inh | 0.022 |
CYP3a4-sub | 0.281 |
CL | 7.166 |
T12 | 0.749 |
hERG | 0.014 |
Ames | 0.024 |
ROA | 0.042 |
SkinSen | 0.713 |
Carcinogencity | 0.555 |
EI | 0.984 |
Respiratory | 0.159 |
NR-Aromatase | 0.003 |
Antiviral | Yes |
Prediction | 0.74142 |